KDM1A and triple-negative breast carcinoma: observed the increasing proportion of CD8+ T cells and the ratio of CD8+ T cells to Tregs (CD8/Treg) in TME of triple-negative breast cancer (TNBC) when treating with an innovative hydrogel-loaded LSD1 inhibitor GSK-LSD1 (36).